Rhenman & Partners Asset Management AB boosted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 165,000 shares of the medical research company’s stock after acquiring an additional 5,000 shares during […]
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Exact Sciences Corporation (NASDAQ:EXAS) is the gene therapy stock with the greatest potential.
TD Asset Management Inc lowered its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 8.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 385,215 shares of the medical research company’s stock after selling 34,655 shares during […]
TFO Wealth Partners LLC raised its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 76,466.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,594 shares of the medical research company’s stock after acquiring an additional 4,588 shares during the […]